• News
  • Medical

La Jolla Pharma issued notice of allowance for patent

La Jolla Pharmaceutical Co. (Nasdaq: LJPC) reported that the U.S. Patent and Trademark Office issued a notice of allowance for its patent application covering methods of treating chronic inflammation by using modified pectin.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!